Critical Illness Neuromuscular Syndromes

Critical Care Clinics

Volumn 22, Issue 4, 2006, Pages 805-818

  De Jonghe, Bernard ^a   Lacherade, Jean Claude ^a   Durand, Marie Christine ^b   Sharshar, Tarek ^b  

^a CENTRE HOSPITALIER INTERCOMMUNAL   (France)

^b RAYMOND POINCARÉ HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; INTERLEUKIN 1; INTERLEUKIN 6; MIFEPRISTONE; NEUROMUSCULAR BLOCKING AGENT; NITRIC OXIDE; TUMOR NECROSIS FACTOR ALPHA;

ARTIFICIAL VENTILATION; BLOOD GLUCOSE MONITORING; BREATHING MUSCLE; CARDIOPULMONARY INSUFFICIENCY; CRITICAL ILLNESS; ELECTROPHYSIOLOGY; GUILLAIN BARRE SYNDROME; HUMAN; HYPERGLYCEMIA; HYPERKALEMIA; INTENSIVE CARE UNIT; LIMB WEAKNESS; MULTIPLE ORGAN FAILURE; MUSCLE WEAKNESS; NEUROMUSCULAR DISEASE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RESPIRATORY DISTRESS; REVIEW; RISK FACTOR; SCORING SYSTEM; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; TRACHEOSTOMY;

CRITICAL CARE; CRITICAL ILLNESS; HUMANS; NEUROMUSCULAR DISEASES;

EID: 33846224332     PISSN: 07490704     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ccc.2006.08.001     Document Type: Review

References (69)

1. Bolton C.F., Gilbert J.J., Fhahn A., et al. Polyneuropathy in critically ill patients. J Neurol Neurosurg Psychiatr 47 (1984) 1223-1231
2. Zochodne D., and Ramsay D. Acute quadriplegic myopathy. Neurology 44 (1994) 988-989
3. Kleyweg R.P., van der Meche F.G., and Meulstee J. Treatment of Guillain-Barre syndrome with high-dose gammaglobulin. Neurology 38 (1988) 1639-1641
4. Kleyweg R.P., van der Meche F.G., and Schmitz P.I. Interobserver agreement in the assessment of muscle strength and functional abilities in Guillain-Barré syndrome. Muscle Nerve 14 (1991) 1103-1109
5. De Jonghe B., Sharshar T., Lefaucheur J.P., et al. Paresis acquired in the intensive care unit: a prospective multicenter study. JAMA 288 (2002) 2859-2867
6. Leijten F.S., Harinck-de-Weerd J.E., Poortvliet D.C., et al. The role of polyneuropathy in motor convalescence after prolonged mechanical ventilation. JAMA 275 (1995) 442-443
7. van der Schaaf M., Beelen A., and de Groot I.J. Critical illness polyneuropathy: a summary of the literature on rehabilitation outcome. Disabil Rehabil 22 (2000) 808-810
8. Herridge M.S., Cheung A.M., Tansey C.M., et al. One-year outcomes in survivors of the acute respiratory distress syndrome. N Engl J Med 348 (2003) 683-693
9. De Jonghe B., Cook D., Sharshar T., et al. Acquired neuromuscular disorders in critically ill patients: a systematic review. Intensive Care Med 24 (1998) 1242-1250
10. Bednarik J., Lukas Z., and Vondracek P. Critical illness polyneuromyopathy: the electrophysiological components of a complex entity. Intensive Care Med 29 (2003) 1505-1514
11. Douglass J. Myopathy in severe asthma. Am Rev Respir Dis 146 (1992) 517-519
12. Leijten F., de-Weerd A., Poortvliet D., et al. Critical illness polyneuropathy in multiple organ dysfunction syndrome and weaning from the ventilator. Intensive Care Med 22 (1996) 856-861
13. Thiele R.I., Jakob H., Hund E., et al. Critical illness polyneuropathy: a new iatrogenically induced syndrome after cardiac surgery?. Eur J Cardiothorac Surg 12 (1997) 826-835
14. Thiele R.I., Jakob H., Hund E., et al. Sepsis and catecholamine support are the major risk factors for critical illness polyneuropathy after open heart surgery. Thorac Cardiovasc Surg 48 (2000) 145-150
15. Garnacho-Montero J., Madrazo-Osuna J., Garcia-Garmendia J.L., et al. Critical illness polyneuropathy: risk factors and clinical consequences: a cohort study in septic patients. Intensive Care Med 27 (2001) 1288-1296
16. Druschky A., Herkert M., Radespiel-Troger M., et al. Critical illness polyneuropathy: clinical findings and cell culture assay of neurotoxicity assessed by a prospective study. Intensive Care Med 27 (2001) 686-693
17. Garnacho-Montero J., Amaya-Villar R., Garcia-Garmendia J.L., et al. Effect of critical illness polyneuropathy on the withdrawal from mechanical ventilation and the length of stay in septic patients. Crit Care Med 33 (2005) 349-354
18. Amaya-Villar R., Garnacho-Montero J., Garcia-Garmendia J.L., et al. Steroid-induced myopathy in patients intubated due to exacerbation of chronic obstructive pulmonary disease. Intensive Care Med 31 (2005) 157-161
19. De Jonghe B., Bastuji-Garin S., Sharshar T., et al. Does ICU-acquired paresis lengthen weaning from mechanical ventilation?. Intensive Care Med 30 (2004) 1117-1121
20. Maher J., Rutledge F., Remtulla H., et al. Neuromuscular disorders associated with failure to wean from the ventilator. Intensive Care Med 21 (1995) 737-743
21. Zifko U.A., Zipko H.T., and Bolton C.F. Clinical and electrophysiological findings in critical illness polyneuropathy. J Neurol Sci 159 (1998) 186-193
22. Meade M., Guyatt G., Cook D., et al. Predicting success in weaning from mechanical ventilation. Chest 120 (2001) 400S-424S
23. Laghi F., Cattapan S.E., Jubran A., et al. Is weaning failure caused by low-frequency fatigue of the diaphragm?. Am J Respir Crit Care Med 167 (2003) 120-127
24. Witt N.J., Zochodne D.W., Bolton C.F., et al. Peripheral nerve function in sepsis and multiple organ failure. Chest 99 (1991) 176-184
25. Laghi F., and Tobin M.J. Disorders of the respiratory muscles. Am J Respir Crit Care Med 168 (2003) 10-48
26. Hussain S.N. Respiratory muscle dysfunction in sepsis. Mol Cell Biochem 179 (1998) 125-134
27. Le Bourdelles G., Viires N., Boczkowski J., et al. Effects of mechanical ventilation on diaphragmatic contractile properties in rats. Am J Respir Crit Care Med 149 (1994) 1539-1544
28. Powers S.K., Shanely R.A., Coombes J.S., et al. Mechanical ventilation results in progressive contractile dysfunction in the diaphragm. J Appl Physiol 92 (2002) 1851-1858
29. Sassoon C.S., Zhu E., and Caiozzo V.J. Assist-control mechanical ventilation attenuates ventilator-induced diaphragmatic dysfunction. Am J Respir Crit Care Med 170 (2004) 626-632
30. Campellone J.V., Lacomis D., Kramer D.J., et al. Acute myopathy after liver transplantation. Neurology 50 (1998) 46-53
31. de Letter M.A., Schmitz P.I., Visser L.H., et al. Risk factors for the development of polyneuropathy and myopathy in critically ill patients. Crit Care Med 29 (2001) 2281-2286
32. Bednarik J., Vondracek P., Dusek L., et al. Risk factors for critical illness polyneuromyopathy. J Neurol 252 (2005) 343-351
33. Van den Berghe G., Schoonheydt K., Becx P., et al. Insulin therapy protects the central and peripheral nervous system of intensive care patients. Neurology 64 (2005) 1348-1353
34. Van den Berghe G., Wouters P., Weekers F., et al. Intensive insulin therapy in the critically ill patients. N Engl J Med 345 (2001) 1359-1367
35. Van den Berghe G., Wouters P.J., Bouillon R., et al. Outcome benefit of intensive insulin therapy in the critically ill: insulin dose versus glycemic control. Crit Care Med 31 (2003) 359-366
36. Van den Berghe G., Wilmer A., Hermans G., et al. Intensive insulin therapy in the medical ICU. N Engl J Med 354 (2006) 449-461
37. Annane D., Bellissant E., Bollaert P.E., et al. Corticosteroids for severe sepsis and septic shock: a systematic review and meta-analysis. BMJ 329 (2004) 480
38. Steinberg K.P., Hudson L.D., Goodman R.B., et al. Efficacy and safety of corticosteroids for persistent acute respiratory distress syndrome. N Engl J Med 354 (2006) 1671-1684
39. Segredo V., Caldwell J., Matthay M., et al. Persistent paralysis in critically ill patients after long-term administration of vecuronium. N Engl J Med 327 (1992) 524-528
40. Leatherman J., Fluegel W., David W., et al. Muscle weakness in mechanically ventilated patients with severe asthma. Am J Respir Crit Care Med 153 (1996) 1686-1690
41. Adnet F., Dhissi G., Borron S.W., et al. Complication profiles of adult asthmatics requiring paralysis during mechanical ventilation. Intensive Care Med 27 (2001) 1729-1736
42. Behbehani N.A., Al-Mane F., D'Yachkova Y., et al. Myopathy following mechanical ventilation for acute severe asthma: the role of muscle relaxants and corticosteroids. Chest 115 (1999) 1627-1631
43. Latronico N., Fenzi F., Recupero D., et al. Critical illness myopathy and neuropathy. Lancet 347 (1996) 1579-1582
44. Rich M.M., Bird S.J., Raps E.C., et al. Direct muscle stimulation in acute quadriplegic myopathy. Muscle Nerve 20 (1997) 665-673
45. Hasselgren P.O., and Fischer J.E. Muscle cachexia: current concepts of intracellular mechanisms and molecular regulation. Ann Surg 233 (2001) 9-17
46. Chai J., Wu Y., and Sheng Z.Z. Role of ubiquitin-proteasome pathway in skeletal muscle wasting in rats with endotoxemia. Crit Care Med 31 (2003) 1802-1807
47. Rabuel C., Renaud E., Brealey D., et al. Human septic myopathy: induction of cyclooxygenase, heme oxygenase and activation of the ubiquitin proteolytic pathway. Anesthesiology 101 (2004) 583-590
48. Tiao G., Fagan J., Roegner V., et al. Energy-ubiquitin-dependent muscle proteolysis during sepsis in rats is regulated by glucocorticoids. J Clin Invest 97 (1996) 339-348
49. Brealey D., Brand M., Hargreaves I., et al. Association between mitochondrial dysfunction and severity and outcome of septic shock. Lancet 360 (2002) 219-223
50. Rouleau G., Karpati G., Carpenter S., et al. Glucocorticoid excess induces preferential depletion of myosin in denervated skeletal muscle fibers. Muscle Nerve 10 (1987) 428-438
51. Massa R., Carpenter S., Holland P., et al. Loss and renewal of thick myofilaments in glucocorticoid-treated rat soleus after denervation and reinnervation. Muscle Nerve 15 (1992) 1290-1298
52. McKay L.I., Du Bois D.C., Sun Y.N., et al. Corticosteroid effects in skeletal muscle: gene induction/receptor autoregulation. Muscle Nerve 20 (1997) 1318-1320
53. Hickson R.C., Wegrzyn L.E., Osborne D.F., et al. Alanyl-glutamine prevents muscle atrophy and glutamine synthetase induction by glucocorticoids. Am J Physiol 271 (1996) R1165-R1172
54. Rich M.M., Pinter M.J., Kraner S.D., et al. Loss of electrical excitability in an animal model of acute quadriplegic myopathy. Ann Neurol 43 (1998) 171-179
55. Rich M.M., and Pinter M.J. Crucial role of sodium channel fast inactivation in muscle fibre inexcitability in a rat model of critical illness myopathy. J Physiol 547 (2003) 555-566
56. Vanhorebeek I., De Vos R., Mesotten D., et al. Protection of hepatocyte mitochondrial ultrastructure and function by strict blood glucose control with insulin in critically ill patients. Lancet 365 (2005) 53-59
57. Verheul G.A., de Jongh-Leuvenink J., Op de Coul A.A., et al. Tumor necrosis factor and interleukin-6 in critical illness polyneuromyopathy. Clin Neurol Neurosurg 96 (1994) 300-304
58. Bolton C. Sepsis and the systemic inflammatory response syndrome: neuromuscular manifestations. Crit Care Med 24 (1996) 1408-1416
59. Fenzi F., Latronico N., Refatti N., et al. Enhanced expression of E-selectin on the vascular endothelium of peripheral nerve in critically ill patients with neuromuscular disorders. Acta Neuropathol (Berl) 106 (2003) 75-82
60. Griffiths R.D., Palmer T.E., Helliwell T., et al. Effect of passive stretching on the wasting of muscle in the critically ill. Nutrition 11 (1995) 428-432
61. Brook A.D., Ahrens T.S., Schaiff R., et al. Effect of a nursing-implemented sedation protocol on the duration of mechanical ventilation. Crit Care Med 27 (1999) 2609-2615
62. Kress J., Pohlman A., O'Connor M., et al. Daily interruption of sedative infusions in critically ill patients undergoing mechanical ventilation. N Engl J Med 342 (2000) 1471-1477
63. De Jonghe B., Bastuji-Garin S., Fangio P., et al. Sedation algorithm in critically ill patients without acute brain injury. Crit Care Med 33 (2005) 120-127
64. Mohr M., Englisch L., Roth A., et al. Effects of early treatment with immunoglobulin on critical illness polyneuropathy following multiple organ failure and gram-negative sepsis. Intensive Care Med 23 (1997) 1144-1149
65. Horton W.A., and Fergusson N.V. Hyperkalaemia and cardiac arrest after the use of suxamethonium in intensive care. Anaesthesia 43 (1988) 890-891
66. Hemming A.E., Charlton S., and Kelly P. Hyperkalaemia, cardiac arrest, suxamethonium and intensive care. Anaesthesia 45 (1990) 990-991
67. Dornan R.I., and Royston D. Suxamethonium-related hyperkalaemic cardiac arrest in intensive care. Anaesthesia 50 (1995) 1006
68. Markewitz B.A., and Elstad M.R. Succinylcholine-induced hyperkalemia following prolonged pharmacologic neuromuscular blockade. Chest 111 (1997) 248-250
69. Hughes M., Grant I.S., Biccard B., et al. Suxamethonium and critical illness polyneuropathy. Anaesth Intensive Care 27 (1999) 636-638